These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 17578067)

  • 1. A review of methylnaltrexone, a peripheral opioid receptor antagonist, and its role in opioid-induced constipation.
    Shaiova L; Rim F; Friedman D; Jahdi M
    Palliat Support Care; 2007 Jun; 5(2):161-6. PubMed ID: 17578067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review of the potential role of methylnaltrexone in opioid bowel dysfunction.
    Foss JF
    Am J Surg; 2001 Nov; 182(5A Suppl):19S-26S. PubMed ID: 11755893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifying and Treating Opioid Side Effects: The Development of Methylnaltrexone.
    Moss J
    Anesthesiology; 2019 Jan; 130(1):142-148. PubMed ID: 30277930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylnaltrexone for reversal of constipation due to chronic methadone use: a randomized controlled trial.
    Yuan CS; Foss JF; O'Connor M; Osinski J; Karrison T; Moss J; Roizen MF
    JAMA; 2000 Jan; 283(3):367-72. PubMed ID: 10647800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical status of methylnaltrexone, a new agent to prevent and manage opioid-induced side effects.
    Yuan CS
    J Support Oncol; 2004; 2(2):111-7; discussion 119-22. PubMed ID: 15328815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylnaltrexone bromide for the treatment of opioid-induced constipation in patients with advanced illness--a cost-effectiveness analysis.
    Earnshaw SR; Klok RM; Iyer S; McDade C
    Aliment Pharmacol Ther; 2010 Apr; 31(8):911-21. PubMed ID: 20096019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of methylnaltrexone for the treatment of opioid-induced constipation in critical care patients.
    Sawh SB; Selvaraj IP; Danga A; Cotton AL; Moss J; Patel PB
    Mayo Clin Proc; 2012 Mar; 87(3):255-9. PubMed ID: 22386181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylnaltrexone bromide: new drug for the treatment of opioid-induced bowel dysfunction.
    Baker DE
    Rev Gastroenterol Disord; 2009; 9(3):E84-93. PubMed ID: 19898269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II trial of subcutaneous methylnaltrexone in the treatment of severe opioid-induced constipation (OIC) in cancer patients: an exploratory study.
    Mori M; Ji Y; Kumar S; Ashikaga T; Ades S
    Int J Clin Oncol; 2017 Apr; 22(2):397-404. PubMed ID: 27628064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of methylnaltrexone for the treatment of opiod-induced constipation: a meta-analysis and systematic review.
    Mehta N; O'Connell K; Giambrone GP; Baqai A; Diwan S
    Postgrad Med; 2016; 128(3):282-9. PubMed ID: 26839023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylnaltrexone in treatment of opioid-induced constipation in a pediatric patient.
    Lee JM; Mooney J
    Clin J Pain; 2012 May; 28(4):338-41. PubMed ID: 21876436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of opioid receptor antagonists in the treatment of opioid-induced constipation: a review.
    Leppert W
    Adv Ther; 2010 Oct; 27(10):714-30. PubMed ID: 20799006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylnaltrexone: treatment for opioid-induced constipation.
    Licup N; Baumrucker SJ
    Am J Hosp Palliat Care; 2011 Feb; 28(1):59-61. PubMed ID: 20801917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylnaltrexone for opioid-induced constipation in advanced illness.
    Thomas J; Karver S; Cooney GA; Chamberlain BH; Watt CK; Slatkin NE; Stambler N; Kremer AB; Israel RJ
    N Engl J Med; 2008 May; 358(22):2332-43. PubMed ID: 18509120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylnaltrexone, a novel peripheral opioid receptor antagonist for the treatment of opioid side effects.
    Yuan CS; Israel RJ
    Expert Opin Investig Drugs; 2006 May; 15(5):541-52. PubMed ID: 16634692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of intravenous methylnaltrexone on opioid-induced gut motility and transit time changes in subjects receiving chronic methadone therapy: a pilot study.
    Yuan SC; Foss FJ; O'Connor M; Osinski J; Roizen FM; Moss J
    Pain; 1999 Dec; 83(3):631-635. PubMed ID: 10568873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylnaltrexone Versus Naloxone for Opioid-Induced Constipation in the Medical Intensive Care Unit.
    Merchan C; Altshuler D; Papadopoulos J
    Ann Pharmacother; 2017 Mar; 51(3):203-208. PubMed ID: 28168885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylnaltrexone for opioid-induced constipation.
    Belavic JM
    Nurse Pract; 2009 Mar; 34(3):6-7. PubMed ID: 19240629
    [No Abstract]   [Full Text] [Related]  

  • 19. Methylnaltrexone: MNTX.
    Drugs R D; 2006; 7(6):374-8. PubMed ID: 17073520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylnaltrexone mechanisms of action and effects on opioid bowel dysfunction and other opioid adverse effects.
    Yuan CS
    Ann Pharmacother; 2007 Jun; 41(6):984-93. PubMed ID: 17504835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.